Canadian Biomaterials Society
La Société Canadienne des Biomatériaux

Happy Monday There are two upcoming events that may be of interest to CBS members and our local biomaterials community...

Abstract deadline extended We are happy to announce that the CBS 2025 abstract submission deadline for the 39th Annual Meeting of the Canadian Biomaterial Society has been extended until January 30th, 2025 The CBS2025 Organizing Committee invites you to submit your abstracts related to biomaterials research through the Oxford Abstracts submission portal...

Calling all abstracts The CBS2025 Organizing Committee invites you to submit your abstracts related to biomaterials research through the Oxford Abstracts submission portal...

We present a nano-spray therapy for on-the spot-repair of a heart attack. Our sprayable therapy uses nano-engineered peptide-based materials, where nanomolar concentrations of surface engineered spherical nanogold are used to coat the surface of the cardiac muscle...

Doxorubicin is widespread and influential apoptosis-inducing drug in cancer chemotherapy which interdicts DNA replication and treats different types of cancers including, benign, potentially-malignant, glioblastoma malignant tumours 1 2 3 ...

Injuries and ailments affecting the spinal cord and brain are among the most debilitating known to mankind...

Metal by-products, including metal ions, released in greater amount from metal-on-metal MM hip implants than from metal-on-polyethylene implants are a cause for concern as they can compromise the functionality and survivorship of the implants due to adverse tissue reactions 1, 2 ...

Protein adsorption is an initial biological response to biomaterials and precedes cellular adhesion, thrombus formation, and inflammation...